KRAS and lysosomal storage disease: Indeed, this has been shown specifically for peptides that have been incorrectly reported to have on-target cellular activity against KRAS.15 Recently, it was demonstrated that these features can also lead to phospholipidosis, at least when present in small molecules.26 Thus, we applied a host of chemical and biological controls in our studies.